Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
This analysis points to fund families that consistently stood out in index fund history, helping you recognize dominant players over time.
25,021 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
As economists flag recession risk and AI reshapes jobs, a new wave of stress tests workplaces. brené brown warns amer...
Option Care earnings season sheds light on the shifting landscape of home infusion and specialty care. This guide bre...
March 2026 brings a crowded field of Seeking Alpha alternatives. Traders now weigh real-time data, crowd insights, an...
California Gov. Gavin Newsom warned 15 cities and counties they have 30 days to align their zoning with SB 79 or face...
Lane Generational just disclosed a sizeable stake in Evolv Technologies, signaling potential interest from big invest...
As Neogen gears up for Q3 2026 earnings, investors are digging for signals beyond the headline numbers. This article ...
May 2026 hands investors a surprise: a big jump in M2 money supply could rekindle inflation pressures. Markets weigh ...
When Wells Fargo reports earnings, the spotlight isn’t just on per-share figures. The real story this quarter is net ...
Walmart is redefining retail competition with a bold mix of groceries, everyday low prices, and omnichannel strength....
Circle Inc.’s public shares jumped again on Tuesday as Bernstein maintained an upbeat view on the company, pointing t...
The Trump administration is weighing a measure to compensate TSA officers who have gone unpaid during a prolonged par...